ผลข้างเคียงจากรังสีรักษาและวิธีการตรวจ เพื่อทำนายโอกาสในการเกิดผลข้างเคียง ซึ่งนำไปสู่ข้อมูลพื้นฐานเฉพาะบุคคล
References
Azria D, Gourgou S, Sozzi WJ, Zouhair A, Mirimanoff RO, Kramer A, et al. Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fi brosis in hypersensitive patients. Br J Cancer 2004;91:1251-60.
Azria D, Ozsahin M, Gligorov J, Zaman K, Llacer Moscardo C, Lemanski C, et al. How to combine hormonotherapy and radiation treatment in adjuvant breast cancer? Cancer Radiother 2008;12:37-41.
Azria D, Ozsahin M, Kramar A, Peters S, Atencio DP, Crompton NE, et al. Single nucleotide polymorphisms, apoptosis and the development of severe late adverse effects following radiotherapy. Clin Cancer Res 2008; in press.
Azria D, Rosenstein BS, Ozsahin M. Radiation-induced side-effects with or without systemic therapies: Primetime for prediction of individual radiosensitivity! Int J. Radiat Oncol Biol Phys 2008; in press.
Buchholz TA. Finding our sensitive patients. Int J. Radiat Oncol Biol Phys 1999;45:547-8.
Cesaretti JA, Stock RG, Lehrer S, Atencio DA, Bernstein JL, Stone NN, et al. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J. Radiat Oncol Biol Phys 2005;61:196-202.
Crompton NE, Ozsahin M. A versatile and rapid assay of radiosensitivity of peripheral blood leukocytes based on DNA and surface-marker assessment of cytotoxicity. Radiat Res 1997;147:55-60.
Crompton NE, Shi YQ, Emery GC, Wisser L, Blattmann H, Maier A, et al. Sources of variation in patient response to radiation treatment. Int J. Radiat Oncol Biol Phys 2001;49:547-54.
Delanian S, Balla-Mekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J. Clin Oncol 1999;17:3283-90.
Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. Randomized, placebo-controlled trial of combined pentoxiphylline and tocopherol for regression of superfi cial radiation-induced fi brosis. J.Clin Oncol 2003;21:2545-50.
Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, et al. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J. Radiat Oncol Biol Phys 2003;55:93-8.
Dewey WC, Ling CC, Meyn RE. Radiation-induced apoptosis: relevance to radiotherapy. Int J. Radiat Oncol Biol Phys 1995;33:781-96.
Dubray B. Late complications of radiotherapy. Role of the time factor. Bull Cancer Radiother 1995;82:98-100.
Dubray B, Delanian S, Lefaix JL. Late effects of mammary radiotherapy on skin and subcutaneous tissues. Cancer Radiother 1997;1:744-52.
Dubray B, Pavy JJ, Giraud P, Danhier S, Cosset JM. Predictive tests of response to radiotherapy. Assessment and perspectives in 1997. Cancer Radiother 1997;1:473-83.
Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J. Radiat Oncol Biol Phys 1991;21:109-22.
Floyd DN, Cassoni AM. Intrinsic radiosensitivity of adult and cord blood lymphocytes as determined by the micronucleus assay. Eur J. Cancer 1994;30:615-20.
Ho AY, Atencio DP, Peters S, Stock RG, Formenti SC, Cesaretti JA, et al. Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. Int J. Radiat Oncol Biol Phys 2006;65: 646-55.
Hoeller U, Borgmann K, Bonacker M, Kuhlmey A, Bajrovic A, Jung H, et al. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 2003;69:137-44.
Huchet A, Caudry M, Belkacemi Y, Trouette R, Vendrely V, Causse N, et al. Volume-effect and radiotherapy [II]. Part II : volume-effect and normal tissue. Cancer Radiother 2003;7:353-62.
Iannuzzi CM, Atencio DP, Green S, Stock RG, Rosenstein BS. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J. Radiat Oncol Biol Phys 2002;52:606-13.
Johansen J, Bentzen SM, Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 1996;40:101-9.
Kiltie AE, Ryan AJ, Swindell R, Barber JB, West CM, Magee B, et al. A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients. Radiother Oncol 1999;51:55-65.
Lartigau E, Dubray B, Mornex F. Biological mechanisms of late effects of ionizing radiations. Cancer Radiother 1997;1:669-76.
Ozsahin M, Crompton NE, Gourgou S, Kramar A, Li L, Shi Y, et al. CD4 amd CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity : A prospective study in 399 patients. Clin Cancer Res 2005;11:7426-33.
Ozsahin M, Ozsahin H, Shi Y, Larsson B, Wurgler FE, Crompton NE. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int J. Radiat Oncol Biol Phys 1997;38:429-40.
Radford IR, Murphy TK. Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA double-strand breakage. Int J. Radiat Biol 1994;65:229-39.
Slonina D, Gasinska A. Intrinsic radiosensitivity of healthy donors and cancer patients as determined by the lymphocyte micronucleus assay. Int J. Radiat Biol 1997;72:693-701.
Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003;4:529-36.
Thames HD, Hendry JH, Moore JV, Ang KK, Travis EL. The high steepness of dose-response curves for late-responding normal tissues. Radiother Oncol 1989;15:49-53.
Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J. Radiat Oncol Biol Phys 2000;47:13-47.
Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-81.
Trowell OA. The sensitivity of lymphocytes to ionising radiation. J Pathol Bacteriol 1952;64:687-704.
Withers HR, Taylor JM, Maciejewski B. Treatment volume and tissue tolerance. Int J. Radiat Oncol Biol Phys 1988;14:751-9.
Azria D, Ozsahin M, Gligorov J, Zaman K, Llacer Moscardo C, Lemanski C, et al. How to combine hormonotherapy and radiation treatment in adjuvant breast cancer? Cancer Radiother 2008;12:37-41.
Azria D, Ozsahin M, Kramar A, Peters S, Atencio DP, Crompton NE, et al. Single nucleotide polymorphisms, apoptosis and the development of severe late adverse effects following radiotherapy. Clin Cancer Res 2008; in press.
Azria D, Rosenstein BS, Ozsahin M. Radiation-induced side-effects with or without systemic therapies: Primetime for prediction of individual radiosensitivity! Int J. Radiat Oncol Biol Phys 2008; in press.
Buchholz TA. Finding our sensitive patients. Int J. Radiat Oncol Biol Phys 1999;45:547-8.
Cesaretti JA, Stock RG, Lehrer S, Atencio DA, Bernstein JL, Stone NN, et al. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J. Radiat Oncol Biol Phys 2005;61:196-202.
Crompton NE, Ozsahin M. A versatile and rapid assay of radiosensitivity of peripheral blood leukocytes based on DNA and surface-marker assessment of cytotoxicity. Radiat Res 1997;147:55-60.
Crompton NE, Shi YQ, Emery GC, Wisser L, Blattmann H, Maier A, et al. Sources of variation in patient response to radiation treatment. Int J. Radiat Oncol Biol Phys 2001;49:547-54.
Delanian S, Balla-Mekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J. Clin Oncol 1999;17:3283-90.
Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. Randomized, placebo-controlled trial of combined pentoxiphylline and tocopherol for regression of superfi cial radiation-induced fi brosis. J.Clin Oncol 2003;21:2545-50.
Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, et al. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J. Radiat Oncol Biol Phys 2003;55:93-8.
Dewey WC, Ling CC, Meyn RE. Radiation-induced apoptosis: relevance to radiotherapy. Int J. Radiat Oncol Biol Phys 1995;33:781-96.
Dubray B. Late complications of radiotherapy. Role of the time factor. Bull Cancer Radiother 1995;82:98-100.
Dubray B, Delanian S, Lefaix JL. Late effects of mammary radiotherapy on skin and subcutaneous tissues. Cancer Radiother 1997;1:744-52.
Dubray B, Pavy JJ, Giraud P, Danhier S, Cosset JM. Predictive tests of response to radiotherapy. Assessment and perspectives in 1997. Cancer Radiother 1997;1:473-83.
Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J. Radiat Oncol Biol Phys 1991;21:109-22.
Floyd DN, Cassoni AM. Intrinsic radiosensitivity of adult and cord blood lymphocytes as determined by the micronucleus assay. Eur J. Cancer 1994;30:615-20.
Ho AY, Atencio DP, Peters S, Stock RG, Formenti SC, Cesaretti JA, et al. Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. Int J. Radiat Oncol Biol Phys 2006;65: 646-55.
Hoeller U, Borgmann K, Bonacker M, Kuhlmey A, Bajrovic A, Jung H, et al. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 2003;69:137-44.
Huchet A, Caudry M, Belkacemi Y, Trouette R, Vendrely V, Causse N, et al. Volume-effect and radiotherapy [II]. Part II : volume-effect and normal tissue. Cancer Radiother 2003;7:353-62.
Iannuzzi CM, Atencio DP, Green S, Stock RG, Rosenstein BS. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J. Radiat Oncol Biol Phys 2002;52:606-13.
Johansen J, Bentzen SM, Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 1996;40:101-9.
Kiltie AE, Ryan AJ, Swindell R, Barber JB, West CM, Magee B, et al. A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients. Radiother Oncol 1999;51:55-65.
Lartigau E, Dubray B, Mornex F. Biological mechanisms of late effects of ionizing radiations. Cancer Radiother 1997;1:669-76.
Ozsahin M, Crompton NE, Gourgou S, Kramar A, Li L, Shi Y, et al. CD4 amd CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity : A prospective study in 399 patients. Clin Cancer Res 2005;11:7426-33.
Ozsahin M, Ozsahin H, Shi Y, Larsson B, Wurgler FE, Crompton NE. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int J. Radiat Oncol Biol Phys 1997;38:429-40.
Radford IR, Murphy TK. Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA double-strand breakage. Int J. Radiat Biol 1994;65:229-39.
Slonina D, Gasinska A. Intrinsic radiosensitivity of healthy donors and cancer patients as determined by the lymphocyte micronucleus assay. Int J. Radiat Biol 1997;72:693-701.
Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003;4:529-36.
Thames HD, Hendry JH, Moore JV, Ang KK, Travis EL. The high steepness of dose-response curves for late-responding normal tissues. Radiother Oncol 1989;15:49-53.
Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J. Radiat Oncol Biol Phys 2000;47:13-47.
Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-81.
Trowell OA. The sensitivity of lymphocytes to ionising radiation. J Pathol Bacteriol 1952;64:687-704.
Withers HR, Taylor JM, Maciejewski B. Treatment volume and tissue tolerance. Int J. Radiat Oncol Biol Phys 1988;14:751-9.
Downloads
Published
2010-12-30
How to Cite
1.
กำเนิดศุภผล พ, หล่อวิทยา ว, ชิตาพนารักษ์ อ, ธราวิจิตรกุล เ, สุขถมยา ว. ผลข้างเคียงจากรังสีรักษาและวิธีการตรวจ เพื่อทำนายโอกาสในการเกิดผลข้างเคียง ซึ่งนำไปสู่ข้อมูลพื้นฐานเฉพาะบุคคล. J Thai Assn of Radiat Oncol [Internet]. 2010 Dec. 30 [cited 2024 Nov. 15];16(2):49-58. Available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/203504
Issue
Section
Original articles
License
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารมะเร็งวิวัฒน์ ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับ และบุคคลากรท่านอื่น ๆ ใน สมาคมฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใดๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
